FDA Inspection 581482 — Gayheart Pharmaceuticals

Gayheart Pharmaceuticals — FEI 3006444604

The FDA completed an inspection of Gayheart Pharmaceuticals on May 11, 2009 in Clearwater, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
May 11, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Clearwater, FL (United States)

Citations

IDCFRDescription
149521 CFR 211.122(a)Written procedures describing in detail
197521 CFR 211.182Written records kept in individual logs
200921 CFR 211.188Prepared for each batch, include complete information